deltatrials
Completed OBSERVATIONAL NCT04669418

Host RNA Signature in Children With Cancer and Infection

Host RNA Signature to Discriminate Bacterial From Viral Infection and Non-specific Inflammation in Children With Cancer

Sponsor: Børnecancerfonden

Conditions Childhood Cancer Infection Neutropenia, Febrile
Interventions RNA expression signature
Updated 5 times since 2021 Last updated: Dec 21, 2022 Started: Jun 1, 2019 Primary completion: Jul 31, 2021 Completion: Jul 31, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04669418, this observational or N/A phase trial focuses on Childhood Cancer and Infection and remains completed. Sponsored by Børnecancerfonden, it has been updated 5 times since 2019, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotRecruiting~Dec 2021 – ~Jan 2023 · 13 months · monthly snapshotRecruiting~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 24 months · monthly snapshotCompleted

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2023 — Jul 2024 [monthly]

    Completed

    Status: Recruiting → Completed

  4. Dec 2021 — Jan 2023 [monthly]

    Recruiting

  5. Jan 2021 — Dec 2021 [monthly]

    Recruiting

    First recorded

Jun 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Børnecancerfonden
  • Danish Cancer Society
  • Lundbeck Foundation
  • Rigshospitalet, Denmark
Data source: Rigshospitalet, Denmark

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations